These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10488711)

  • 21. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.
    Alexander J; Torbenson M; Wu TT; Yeh MM
    J Gastroenterol Hepatol; 2013 May; 28(5):848-54. PubMed ID: 23302015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
    Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
    Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.
    Dutta U; Kench J; Byth K; Khan MH; Lin R; Liddle C; Farrell GC
    Hum Pathol; 1998 Nov; 29(11):1279-84. PubMed ID: 9824107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma in cirrhotic liver in Trieste.
    Melato M; Valente M; Mucli E; Muuse MM; Taraglio S
    J Gastroenterol Hepatol; 1989; 4(6):521-7. PubMed ID: 2562353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: a retrospective clinical-pathological study.
    K-Kutala B; Bedossa P; Guedj J; Asselah T; Martinot-Peignoux M; Duval X; Marcellin P
    Dig Liver Dis; 2015 Apr; 47(4):296-302. PubMed ID: 25596930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.
    Van Roey G; Fevery J; Van Steenbergen W
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):61-6. PubMed ID: 10656212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.
    Chevret S; Trinchet JC; Mathieu D; Rached AA; Beaugrand M; Chastang C
    J Hepatol; 1999 Jul; 31(1):133-41. PubMed ID: 10424293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
    van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of hepatocellular carcinoma in Italy.
    Stroffolini T; Andreone P; Andriulli A; Ascione A; Craxi A; Chiaramonte M; Galante D; Manghisi OG; Mazzanti R; Medaglia C; Pilleri G; Rapaccini GL; Simonetti RG; Taliani G; Tosti ME; Villa E; Gasbarrini G
    J Hepatol; 1998 Dec; 29(6):944-52. PubMed ID: 9875641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
    Allaire M; Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; DI Martino V; Sutton A; Letouzé E; Audureau E; Roudot-Thoraval F;
    Hepatology; 2018 Oct; 68(4):1245-1259. PubMed ID: 29663511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients.
    Nzeako UC; Goodman ZD; Ishak KG
    Am J Clin Pathol; 1996 Jan; 105(1):65-75. PubMed ID: 8561091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey.
    Sagnelli E; Stroffolini T; Sagnelli C; Smedile A; Morisco F; Furlan C; Babudieri S; Brancaccio G; Coppola N; Gaeta GB; Almasio PL;
    Dig Liver Dis; 2016 Sep; 48(9):1066-71. PubMed ID: 27291331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
    de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
    Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
    Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
    J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.
    Leung C; Yeoh SW; Patrick D; Ket S; Marion K; Gow P; Angus PW
    World J Gastroenterol; 2015 Jan; 21(4):1189-96. PubMed ID: 25632192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.